Accelerating nerve regeneration with botulinum toxin and electrical stimulation therapies

Information

  • Research Project
  • 10135331
  • ApplicationId
    10135331
  • Core Project Number
    R03HD101090
  • Full Project Number
    1R03HD101090-01A1
  • Serial Number
    101090
  • FOA Number
    PAR-20-042
  • Sub Project Id
  • Project Start Date
    4/5/2021 - 3 years ago
  • Project End Date
    3/31/2023 - a year ago
  • Program Officer Name
    BONNER, JOSEPH FRANCIS
  • Budget Start Date
    4/5/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    4/5/2021 - 3 years ago

Accelerating nerve regeneration with botulinum toxin and electrical stimulation therapies

Project Summary Peripheral nerve injuries are an under-appreciated public health problem. There are about 200,000 new cases per year in the USA. Recovery is incomplete for the vast majority of patients who suffer from one because nerve regrowth is slow and inefficient. Unfortunately, there are no approved treatments to improve the process of nerve regeneration. We have identified two complimentary therapies in order to target the (i) early and (ii) late phases of the nerve regeneration process. They each may work as stand-alone therapy or potentially in combination, as we predict they will have an additive benefit on nerve repair. The present proposal will set the stage for a follow up clinical trial to bring the most promising therapy to patients. We believe we can make rapid progress towards this goal because one therapy represents a repurposing of an already FDA-approved drug, and the other therapy is a form of electrical stimulation that already has shown efficacy in small clinical trials for nerve injury. The electrical stimulation therapy is in need of a new mode of delivery to remove barriers to clinical implementation, which we offer by means of novel transient bio-electric implant system. Overall, this proposal will deliver a new horizon in how we can improve the treatment of patients with peripheral nerve injuries to maximize their functional recovery.

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
  • Activity
    R03
  • Administering IC
    HD
  • Application Type
    1
  • Direct Cost Amount
    121885
  • Indirect Cost Amount
    55181
  • Total Cost
    177066
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:177066\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZHD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    REHABILITATION INSTITUTE OF CHICAGO D/B/A SHIRLEY RYAN ABILITYLAB
  • Organization Department
  • Organization DUNS
    068477546
  • Organization City
    CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    606113167
  • Organization District
    UNITED STATES